Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration
Patients with gout are more likely to receive long-term opioids than counterparts without gout, independent of other factors. This risk is greater in underrepresented gout populations, those with greater comorbidity, patients requiring rheumatology consultations, and individuals prescribed urate-lowering treatments. Additional investigation is needed to elucidate whether deployment of optimal gout management minimizes long-term opioid exposure in patients with gout.
Authors
- Punyasha Roul
- Tuhina Neogi (ORCID: https://orcid.org/0000-0002-9515-1711)
- Lindsay N. Helget (ORCID: https://orcid.org/0000-0001-7716-209X)
- Harlan R Sayles (ORCID: https://orcid.org/0000-0002-4082-8289)
- Ted R. Mikuls (ORCID: https://orcid.org/0000-0002-0897-2272)
- Bryant R. England (ORCID: https://orcid.org/0000-0002-9649-3588)
- Joshua F. Baker (ORCID: https://orcid.org/0000-0003-0170-028X)
- James R. O’Dell
Institutions
- Boston University (US)
- Philadelphia VA Medical Center (US)
- VA Nebraska Western Iowa Health Care System (US)
- University of Nebraska Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1002/acr.25622
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00